(319g) Quantifying Effects of Polar Lipid Proportions on Model Tear Film Stability
AIChE Annual Meeting
2021
2021 Annual Meeting
Engineering Sciences and Fundamentals
Interfacial Phenomena in Pharmaceutics
Tuesday, November 9, 2021 - 1:30pm to 1:45pm
One commonly accepted model of the tear film splits the lipid layer into two subphases - a nonpolar lipid phase, which contacts air, and a polar lipid phase, which resides at the interface between the aqueous layer and the lipid layer. Phospholipids are generally assumed to be the main constituent of the polar lipid phase and are believed to play an important role in stabilizing the tear film, in part due to their ability to reduce the critical film thickness for dewetting of thin films.
However, despite recent efforts to investigate the role of phospholipids in tear film stability, the effect of changes in the lipid layerâs phospholipid proportion on tear film stability is still not fully understood. To address this gap, we will investigate how varying proportions of the phospholipid dipalmitoyl phosphatidylcholine (DPPC) in the lipid layer affect the stability of a simplified in vitro model tear film comprised of artificial tear solution (ATS), DPPC, and stearyl stearate, which model the aqueous layer, polar phase of the lipid layer, and nonpolar phase of the lipid layer, respectively.
We will first quantify tear film stability through use of the previously developed Interfacial Dewetting and Drainage Optical Platform (i-DDrOP), which allows for the spatiotemporal imaging of thin liquid films over curved substrates. We will then characterize the surface properties of these model tear films with measurements of surface tension and interfacial viscoelasticity to investigate how surface rheology impacts tear film stability in this system. Altogether, this work aims to advance our understanding of the role of phospholipids in stabilizing human tear films, in an effort to illuminate fundamental causes of ocular surface diseases such as DES and guide future avenues of therapeutic research.